IMPACT OF HYPOKALEMIA ON HEPATIC ENCEPHALOPATHY AND ITS EFFECT ON DURATION OF STAY IN HOSPITAL

Authors

  • Mirza Waseem Javed Pak Emirates Military Hospital, Rawalpindi-Pakistan
  • Ejaz Ahmad PAF Hospital, Islamabad-Pakistan
  • Hassaan Ahmad Rehman Medical College, Peshawar-Pakistan
  • Zameer Ahmad Nayyer PAF Hospital, Islamabad-Pakistan

Keywords:

Hepatic Encephalopathy, Hypokalemia, Liver Cirrhosis, Alkalosis

Abstract

Background: Hypokalemia is one of the most important precipitating factors of hepatic encephalopathy causing Hypokalemic Alkalosis which is the leading cause of increased levels of nonionic ammonia in blood that crosses the blood brain barrier with ease and accumulates in the Central Nervous System. Methods: A descriptive study was conducted in the Department of Medicine, PAF Hospital, Islamabad from December 31, 2022, to January 1, 2024.The sample size was calculated using WHO sample size calculator and non-probability sampling technique was used. Calculation of mean and standard deviation for variables like Age, Potassium levels and Length of Hospital Stay was done. Frequencies and percentages were calculated for variables like Hypokalemia, Gender, and Ethnicity. Independent samples t-test was used to compare the means, duration of stay at the hospital for patients with and without hypokalemia, keeping the p-value <0.05 as significant. Results: The mean age of patients was 36.76±9.52 years. Out of the total 179 patients considered, 109 patients were male while 70 were females. Sixty-three patients were found to have hypokalemia. Their mean Potassium level was 3.47±0.37 mEq/L. A significant difference (p=0.230) wasn’t detected in patients presenting with hypokalemia with age greater than and less than 35 years of age whereas, a significant difference (<0.001) was detected in the age group of less than 35 years when mean length of hospital stay was calculated. Conclusion: The mean length of hospital stay was significantly higher amongst patients having hypokalemia, compared to those with no hypokalemia.

References

Shelly CP, Sridhar K, Srinivas MG, Harish KY. In Hospital Mortality Related to Cirrhosis of liver In a Tertiary Care Rural Hospital. Sch J App Med Sci 2014;2(2D):790–5.

Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S, Jafri W. Precipitating Factors and the outcome of Hepatic Encaphalopathy in liver cirrhosis. J Coll Physicians Surg Pak 2010;20(8):514–8.

Masood N, Rahopoto Q, Gouri A, Munir A. Precipitating factors of hepatic Encaphalopathy in Cirrhosis of liver. Med Channel 2010;16(3):376–9.

Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011;17(2):RA53–63.

Hayat AS, Shaikh N, Memon F. Identification of Precipitating Factors in Hepatic Encephalopathy in Patients at liaquat University Hospital Jamhoro. World Appl Sci J 2010;8(6):661–6.

Munoz SJ. Hepatic encephalopathy. Med Clin North Am 2008;92(4):795–812.

Gadupati V, Chandrala C, Abbas N, Tariq H, Chillimuri S, Balar B. Prognostic Significance of hypokalemia in Hepatic Encephalopathy. Hepatogastroenterology 2014;61(133):1170–4.

Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(Suppl 1):3–9.

Moriwaki H, Shiraki M, Iwasa J, Terakura Y. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective: Encephalopathy in Asian liver cirrhosis. J Gastroenterol Hepatol 2010;25(5):858–63.

Yang SS, Wu CH, Chiang TR, Chen DS. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology 1998;27(2):357–61.

Onji M. Etiologies and Characteristics of Liver Cirrhosis in Japan 1998-2008. Chugai Igaku Co Ltd Tokyo Jpn 1998;1–10.

El-Garem AA. Schistosomiasis. Digestion 1998;59(5):589–605.

Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34(4):275–8.

Krapf R, Beeler I, Hertner D, Hulter HN. Chronic respiratory alkalosis. The effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med 1991;324(20):1394–401.

Casey TH, Summerskill WH, Bickford RG, Rosevear JW. Body and serum potassium in liver disease. Ii. Relationships to arterial ammonia, blood ph, and hepatic coma. Gastroenterology 1965;48:208–15.

Casey TH, Summerskill WH, Orvis AL. Body and serum potassium in liver disease. I. Relationship to hepatic function and associated factors. Gastroenterology 1965;48:198–207.

Read AE, Laidlaw J, Haslam RM, Sherlock S. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin Sci 1959;18:409–23.

Isaac G, Holland OB. Drug-induced hypokalaemia. A cause for concern. Drugs Aging 1992;2(1):35–41.

Laffi G, La Villa G, Carloni V, Foschi M, Bartoletti L, Quartini M, et al. Loop diuretic therapy in liver cirrhosis with ascites. J Cardiovasc Pharmacol 1993;22(Suppl 3):S51–8.

Gabduzda GJ, Hall PW 3rd. Relation of potassium depletion to renal ammonium metabolism and hepatic coma. Medicine (Baltimore) 1966;45(6):481–90.

Stéphan F, Paillard F. Terlipressin-exacerbated hypokalaemia. Lancet 1998;351(9111):1249–50.

Published

2024-09-08